These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18754727)

  • 41. International Proteolysis Society in association with the International Conference on Protease Inhibitors--second general meeting.
    Schmitt M
    IDrugs; 2001 Dec; 4(12):1361-4. PubMed ID: 15931566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors.
    Buchini S; Buschiazzo A; Withers SG
    Angew Chem Int Ed Engl; 2008; 47(14):2700-3. PubMed ID: 18300214
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibitors of hepatitis C virus NS3/4A: alpha-ketoamide based macrocyclic inhibitors.
    Avolio S; Robertson K; Hernando JI; DiMuzio J; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2295-8. PubMed ID: 19285390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of selective Cathepsin inhibitors.
    Bethel PA; Gerhardt S; Jones EV; Kenny PW; Karoutchi GI; Morley AD; Oldham K; Rankine N; Augustin M; Krapp S; Simader H; Steinbacher S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4622-5. PubMed ID: 19616430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
    Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.
    Heim-Riether A; Taylor SJ; Liang S; Gao DA; Xiong Z; Michael August E; Collins BK; Farmer BT; Haverty K; Hill-Drzewi M; Junker HD; Mariana Margarit S; Moss N; Neumann T; Proudfoot JR; Keenan LS; Sekul R; Zhang Q; Li J; Farrow NA
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5321-4. PubMed ID: 19692239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chalcones from Bauhinia glauca subsp. pernervosa].
    Wu Z; Wang B; Zhao Y; Yang X; Liang H
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(13):1676-8. PubMed ID: 19873779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE.
    Wu YJ; Zhang Y; Good AC; Burton CR; Toyn JH; Albright CF; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2009 May; 19(10):2654-60. PubMed ID: 19375914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.
    Yamaguchi Y; Menear K; Cohen NC; Mah R; Cumin F; Schnell C; Wood JM; Maibaum J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4863-7. PubMed ID: 19615901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the genotoxic potential of Bauhinia monandra leaf lectin (BmoLL).
    Sisenando HA; Macedo MF; Saturnino AC; Coelho LC; de Medeiros SR
    Food Chem Toxicol; 2009 Feb; 47(2):303-8. PubMed ID: 19041921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.
    Charrier N; Clarke B; Demont E; Dingwall C; Dunsdon R; Hawkins J; Hubbard J; Hussain I; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3669-73. PubMed ID: 19477642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrocyclic inhibitors of HCV NS3 protease.
    Venkatraman S; Njoroge FG
    Expert Opin Ther Pat; 2009 Sep; 19(9):1277-303. PubMed ID: 19563268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibitors as factors regulating proteolysis].
    Kazanskaia NF
    Bioorg Khim; 1994 May; 20(5):485-91. PubMed ID: 8053943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.
    Burnett JC; Wang C; Nuss JE; Nguyen TL; Hermone AR; Schmidt JJ; Gussio R; Wipf P; Bavari S
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5811-3. PubMed ID: 19703771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. O-GlcNAc peptide epoxyketones are recognized by mammalian proteasomes.
    Witte MD; Florea BI; Verdoes M; Adeyanju O; Van der Marel GA; Overkleeft HS
    J Am Chem Soc; 2009 Sep; 131(34):12064-5. PubMed ID: 19658393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
    Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F
    J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
    Morrison CJ; Butler GS; Rodríguez D; Overall CM
    Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Brain proteinase activity and the mobilization of endogenous proteolytic inhibitors as factors in the development of the functional state of the body].
    Gurin VN; Sandakov DB; Gurin AV
    Fiziol Cheloveka; 1999; 25(1):71-7. PubMed ID: 10204297
    [No Abstract]   [Full Text] [Related]  

  • 60. Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets.
    Bonturi CR; Silva Teixeira AB; Rocha VM; Valente PF; Oliveira JR; Filho CMB; Fátima Correia Batista I; Oliva MLV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.